Humacyte Inc.
1.74
0.19 (12.26%)
At close: Jan 15, 2025, 3:51 PM
1.74
0.00%
After-hours Jan 15, 2025, 03:52 PM EST

Humacyte Statistics

Share Statistics

Humacyte has 128.67M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding 128.67M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Institutions (%) n/a
Shares Floating -
Failed to Deliver (FTD) Shares -
FTD / Avg. Volume -%

Short Selling Information

The latest short interest is 0, so 0% of the outstanding shares have been sold short.

Short Interest 0
Short % of Shares Out 0%
Short % of Float 0%
Short Ratio (days to cover) 0

Valuation Ratios

The PE ratio is -2.65 and the forward PE ratio is null.

PE Ratio -2.65
Forward PE null
PS Ratio 0
Forward PS null
PB Ratio 21.68
P/FCF Ratio -3.89
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Humacyte Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.52, with a Debt / Equity ratio of 2.85.

Current Ratio 4.52
Quick Ratio 4.52
Debt / Equity 2.85
Total Debt / Capitalization 74.02
Cash Flow / Debt -1.9
Interest Coverage -88.38

Financial Efficiency

Return on equity (ROE) is -8.18% and return on capital (ROIC) is -140.81%.

Return on Equity (ROE) -8.18%
Return on Assets (ROA) -0.86%
Return on Capital (ROIC) -140.81%
Revenue Per Employee 0
Profits Per Employee -605.33K
Employee Count 183
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.47, so Humacyte 's price volatility has been higher than the market average.

Beta 1.47
52-Week Price Change null%
50-Day Moving Average 1.7
200-Day Moving Average 1.73
Relative Strength Index (RSI) 44.23
Average Volume (20 Days) -

Income Statement

Revenue n/a
Gross Profit -76.55M
Operating Income -100.05M
Net Income -110.78M
EBITDA -96.46M
EBIT n/a
Earnings Per Share (EPS) -1.07
Full Income Statement

Balance Sheet

The company has 80.45M in cash and 57.51M in debt, giving a net cash position of 22.94M.

Cash & Cash Equivalents 80.45M
Total Debt 57.51M
Net Cash 22.94M
Retained Earnings -537.31M
Total Assets 114.76M
Working Capital 2.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73.31M and capital expenditures -2.28M, giving a free cash flow of -75.58M.

Operating Cash Flow -73.31M
Capital Expenditures -2.28M
Free Cash Flow -75.58M
FCF Per Share -0.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HUMAW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for HUMAW.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -11.24
Piotroski F-Score 3